<DOC>
	<DOCNO>NCT00766779</DOCNO>
	<brief_summary>A study compare conventional chemotherapy low dose total body irradiation-based conditioning hematopoietic cell transplantation relate unrelated donor consolidation therapy old Patients AML first Complete Remission .</brief_summary>
	<brief_title>HCT Versus CT Elderly AML</brief_title>
	<detailed_description>The majority patient acute myelogenous leukaemia ( AML ) enter complete remission follow induction therapy , relapse despite consolidation maintenance therapy . In response , post-remission treatment progressively intensified result improve either high-dose post-remission therapy autologous hematopoietic cell transplantation ( HCT ) allogeneic HCT , high curative potential patient AML . Given toxicity dose intensification allogeneic HCT , however , young patient profit treatment approach</detailed_description>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>Age ≥ 60years ≤ 75 year primary secondary AML define WHO refractory anemia excess blast ( RAEB ) First complete remission follow one two cycle induction chemotherapy Chemotherapy administer accord current participate cooperative group protocols Karnofsky score ≥ 70 Written inform consent AML FAB M3 HIV positivity Participation another clinical trial without prior consent coordinate investigator , patient may exceptionally take part study The second study exclusively concern induction therapy Consolidation cycle one two give accord accredited study group policy No investigational drug use post registration HCT v CT eldery AML study . Documentation HCT v CT eldery AML study compromise . Second hand data foreign study accept</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>hematopoietic cell transplantation</keyword>
	<keyword>Acute Myeloid Leukemia</keyword>
	<keyword>first Complete Remission</keyword>
</DOC>